Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy.
D000818:Animals; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D004412:Dysmenorrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D009288:Naproxen / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D014590:Uterine Contraction / Q000187:drug effects*
D010919:Placebos; D011453:Prostaglandins; D009288:Naproxen; D007213:Indomethacin